Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
enVVeno Medical Corp | SVP & Chief Medical Officer | Stock Options | 75K | Dec 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NVNO | enVVeno Medical Corp | Dec 18, 2024 | 1 | $0 | 4 | Dec 20, 2024 | SVP & Chief Medical Officer |
NVNO | enVVeno Medical Corp | Dec 5, 2023 | 1 | $0 | 4 | Dec 7, 2023 | SVP & Chief Medical Officer |
NVNO | enVVeno Medical Corp | Nov 30, 2021 | 2 | $0 | 4 | Dec 2, 2021 | SVP & Chief Medical Officer |
NVNO | Hancock Jaffe Laboratories, Inc. | May 21, 2021 | 1 | $9.44K | 4 | May 25, 2021 | SVP & Chief Medical Officer |